Lu YF - Search Results

1

Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study.

Yuan M, Chen TY, Chen XR, Lu YF, Shi J, Zhang WS, Ye C, Tang BZ, Yang ZG. Yuan M, et al. Among authors: lu yf. World J Clin Cases. 2022 Aug 26;10(24):8535-8546. doi: 10.12998/wjcc.v10.i24.8535. World J Clin Cases. 2022. PMID: 36157824 Free PMC article.

2

HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.

Yang Z, Lu Y, Xu Q, Tang B, Park CK, Chen X. Yang Z, et al. Dis Markers. 2015;2015:191029. doi: 10.1155/2015/191029. Epub 2015 Jun 7. Dis Markers. 2015. PMID: 26136615 Free PMC article.

3

Elevation of serum GGT and LDH levels, together with higher BCLC staging are associated with poor overall survival from hepatocellular carcinoma: a retrospective analysis.

Yang Z, Ye P, Xu Q, Lu Y, Tang B, Wang Q, Chen S, Chen X. Yang Z, et al. Discov Med. 2015 Jun;19(107):409-18. Discov Med. 2015. PMID: 26175398 Free article.

4

Correlation of APOBEC3 in tumor tissues with clinico-pathological features and survival from hepatocellular carcinoma after curative hepatectomy.

Yang Z, Lu Y, Xu Q, Zhuang L, Tang B, Chen X. Yang Z, et al. Int J Clin Exp Med. 2015 May 15;8(5):7762-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221327 Free PMC article.

5

Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.

Yang Z, Zhang J, Lu Y, Xu Q, Tang B, Wang Q, Zhang W, Chen S, Lu L, Chen X. Yang Z, et al. Oncotarget. 2015 Dec 15;6(40):43090-8. doi: 10.18632/oncotarget.5719. Oncotarget. 2015. PMID: 26506519 Free PMC article.

6

Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma.

Yang Z, Zhuang L, Yu Y, Zhou W, Lu Y, Xu Q, Tang B, Chen X. Yang Z, et al. Discov Med. 2015 Dec;20(112):349-56. Discov Med. 2015. PMID: 26760979 Free article.

7

Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.

Yang Z, Zhuang L, Lu Y, Xu Q, Tang B, Chen X. Yang Z, et al. Oncotarget. 2016 Mar 15;7(11):12525-36. doi: 10.18632/oncotarget.7123. Oncotarget. 2016. PMID: 26848866 Free PMC article.

8

Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials.

Yang Z, Liao X, Lu Y, Xu Q, Tang B, Chen X, Yu Y. Yang Z, et al. Evid Based Complement Alternat Med. 2017;2017:3428253. doi: 10.1155/2017/3428253. Epub 2017 Jun 7. Evid Based Complement Alternat Med. 2017. PMID: 28680448 Free PMC article. Review.

9

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma.

Shi J, Chen L, Chen Y, Lu Y, Chen X, Yang Z. Shi J, et al. J Cancer. 2019 Aug 27;10(20):4892-4901. doi: 10.7150/jca.32768. eCollection 2019. J Cancer. 2019. PMID: 31598161 Free PMC article.

10

The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis.

Zhang Y, Yang L, Shi J, Lu Y, Chen X, Yang Z. Zhang Y, et al. Biomed Res Int. 2020 Apr 8;2020:3040839. doi: 10.1155/2020/3040839. eCollection 2020. Biomed Res Int. 2020. PMID: 32337237 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters